Fetal stem cells offer hope for babies with brittle bones
NCT ID NCT03706482
First seen Sep 30, 2025 · Last updated Apr 28, 2026 · Updated 30 times
Summary
This study tests whether infusions of donated fetal stem cells can safely help babies with a severe form of osteogenesis imperfecta (brittle bone disease). The treatment aims to reduce fractures and improve bone strength. The trial includes up to 18 children, some treated before and after birth, and compares them to past and current untreated patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOGENESIS IMPERFECTA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Karolinska University Hospital
Stockholm, Stockholm County, 171 76, Sweden
Conditions
Explore the condition pages connected to this study.